New radiation therapy presented at the American Academy of Ophthalmology earlier this month could see patients with wet age-related macular degeneration go as long as a year between treatments.
A study of 21 international sites, including King's College London and Manchester Royal Eye Hospital found that patients given the radiation treatment needed on average a third fewer injections the next year and some needed no injections over the 12-month trial.
The treatment, from US firm Oraya Therapeutics, uses low doses of radiation to treat blood vessels in the macular and was said to take 20 minutes. According The Telegraph (November 20), the treatment has been licensed for UK use.